Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
There is a need for new systemic sclerosis subset criteria. A content analytic approach.
Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Müller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE. Johnson SR, et al. Among authors: van den hoogen f. Scand J Rheumatol. 2018 Jan;47(1):62-70. doi: 10.1080/03009742.2017.1299793. Epub 2017 Oct 9. Scand J Rheumatol. 2018. PMID: 28990485
Effects of immunomodulating therapy in systemic sclerosis.
van den Hoogen FH, Boerbooms AM, van de Putte LB. van den Hoogen FH, et al. Among authors: van de putte lb. Clin Rheumatol. 1990 Sep;9(3):319-24. doi: 10.1007/BF02114391. Clin Rheumatol. 1990. PMID: 2124530 Review.
Treatment of systemic sclerosis.
van den Hoogen FH, van de Putte LB. van den Hoogen FH, et al. Among authors: van de putte lb. Curr Opin Rheumatol. 1994 Nov;6(6):637-41. doi: 10.1097/00002281-199411000-00015. Curr Opin Rheumatol. 1994. PMID: 7865386 Review.
Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies.
van den Hoogen FH, Spronk PE, Boerbooms AM, Bootsma H, de Rooij DJ, Kallenberg CG, van de Putte LB. van den Hoogen FH, et al. Among authors: van de putte lb. Br J Rheumatol. 1994 Dec;33(12):1117-20. doi: 10.1093/rheumatology/33.12.1117. Br J Rheumatol. 1994. PMID: 8000737
Clinical aspects of systemic and localized scleroderma.
van den Hoogen FH, de Jong EM. van den Hoogen FH, et al. Curr Opin Rheumatol. 1995 Nov;7(6):546-50. doi: 10.1097/00002281-199511000-00014. Curr Opin Rheumatol. 1995. PMID: 8579977 Review.
Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial.
van den Hoogen FH, Boerbooms AM, Swaak AJ, Rasker JJ, van Lier HJ, van de Putte LB. van den Hoogen FH, et al. Among authors: van de putte lb, van lier hj. Br J Rheumatol. 1996 Apr;35(4):364-72. doi: 10.1093/rheumatology/35.4.364. Br J Rheumatol. 1996. PMID: 8624641 Free article. Clinical Trial.
Systemic sclerosis: new insights in autoimmunity.
Kaal SE, van Den Hoogen FH, de Jong EM, Viëtor HE. Kaal SE, et al. Among authors: van den hoogen fh. Proc Soc Exp Biol Med. 1999 Oct;222(1):1-8. doi: 10.1111/j.1525-1373.1999.09991.x. Proc Soc Exp Biol Med. 1999. PMID: 10510242 Review.
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C, Finke J, Peter HH, van Laar J, Breedveld FC, Fibbe WE, Farge D, Gluckman E, Locatelli F, Martini A, van den Hoogen F, van de Putte L, Schattenberg AV, Arnold R, Bacon PA, Emery P, Espigado I, Hertenstein B, Hiepe F, Kashyap A, Kötter I, Marmont A, Martinez A, Pascual MJ, Gratwohl A, Prentice HG, Black C, Tyndall A. Binks M, et al. Among authors: van de putte l, van den hoogen f, van laar j. Ann Rheum Dis. 2001 Jun;60(6):577-84. doi: 10.1136/ard.60.6.577. Ann Rheum Dis. 2001. PMID: 11350846 Free PMC article. Clinical Trial.
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres.
Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Becvar R, Bruhlman P, Cozzi F, Czirják L, Drosos AA, Dziankowska B, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Scorza R, Tirri E, van den Hoogen FH, Vlachoyiannopoulos PG. Della Rossa A, et al. Among authors: van den hoogen fh. Ann Rheum Dis. 2001 Jun;60(6):585-91. doi: 10.1136/ard.60.6.585. Ann Rheum Dis. 2001. PMID: 11350847 Free PMC article.
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.
Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Bruhlmann P, Czirják L, De Luca A, Drosos AA, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Rosada M, Scorza R, Stork J, Sysa A, van den Hoogen FH, Vlachoyiannopoulos PJ. Valentini G, et al. Among authors: van den hoogen fh. Ann Rheum Dis. 2001 Jun;60(6):592-8. doi: 10.1136/ard.60.6.592. Ann Rheum Dis. 2001. PMID: 11350848 Free PMC article.
436 results